Investigators from the University of Turin have developed and characterized a new murine immunocompetent model of Usp18-knockout leiomyosarcoma (LMS). LMS is a rare malignant soft tissue cancer with ...

Whenever possible, enrollment in clinical trials is strongly recommended; however, a significant proportion of patients lack access to these opportunities. In such cases, treatment options include ...